These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8005800)

  • 1. Combination of photodynamic therapy (PDT) and melphalan in experimental tumors.
    Sansom JM; Sutton B; Reeves N; Bradley JK; Wood PJ; Bremner JC; Adams GE; Stratford IJ
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):463-6. PubMed ID: 8005800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors.
    Nahabedian MY; Cohen RA; Contino MF; Terem TM; Wright WH; Berns MW; Wile AG
    J Natl Cancer Inst; 1988 Jul; 80(10):739-43. PubMed ID: 3385781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin gallate with photodynamic therapy enhances anti-tumor effects in vivo and in vitro.
    Mun ST; Bae DH; Ahn WS
    Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):141-7. PubMed ID: 24632332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent.
    Henderson BW; Sitnik-Busch TM; Vaughan LA
    Photochem Photobiol; 1999 Jul; 70(1):64-71. PubMed ID: 10420844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
    Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma.
    Uehara M; Sano K; Wang ZL; Sekine J; Ikeda H; Inokuchi T
    Cancer Immunol Immunother; 2000 Oct; 49(8):401-9. PubMed ID: 11043846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models.
    Waldow SM; Henderson BW; Dougherty TJ
    Lasers Surg Med; 1987; 7(1):12-22. PubMed ID: 2952850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.
    Mori M; Sakata I; Hirano T; Obana A; Nakajima S; Hikida M; Kumagai T
    Jpn J Cancer Res; 2000 Jul; 91(7):753-9. PubMed ID: 10920284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
    Zhou Q; Olivo M; Lye KY; Moore S; Sharma A; Chowbay B
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):569-77. PubMed ID: 16001166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.
    Colussi VC; Feyes DK; Mulvihill JW; Li YS; Kenney ME; Elmets CA; Oleinick NL; Mukhtar H
    Photochem Photobiol; 1999 Feb; 69(2):236-41. PubMed ID: 10048316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
    Fingar VH; Mang TS; Henderson BW
    Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.
    Chen B; Roskams T; de Witte PA
    Lasers Surg Med; 2002; 31(3):158-63. PubMed ID: 12224088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo light transmission spectra in EMT6/Ed murine tumors and Dunning R3327 rat prostate tumors during photodynamic therapy.
    Ballangrud AM; Barajas O; Georgousis A; Miller GG; Moore RB; McPhee MS; Tulip J
    Lasers Surg Med; 1997; 21(2):124-33. PubMed ID: 9261789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors.
    Canti G; Lattuada D; Morelli S; Nicolin A; Cubeddu R; Taroni P; Valentini G
    Cancer Lett; 1995 Jul; 93(2):255-9. PubMed ID: 7621437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds.
    Sheldon PW; Batten EL; Adams GE
    Br J Cancer; 1982 Oct; 46(4):525-31. PubMed ID: 7138761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors.
    Canti G; Nicolin A; Cubeddu R; Taroni P; Bandieramonte G; Valentini G
    Cancer Lett; 1998 Mar; 125(1-2):39-44. PubMed ID: 9566694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects and blood flow dynamics after photodynamic therapy using benzoporphyrin derivative monoacid ring A in KLN205 and LM8 mouse tumor models.
    Osaki T; Takagi S; Hoshino Y; Okumura M; Fujinaga T
    Cancer Lett; 2007 Apr; 248(1):47-57. PubMed ID: 16837129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.